We are live on ! Find out more
TC

TFS Capital Portfolio holdings

AUM $255M
1-Year Est. Return 32.31%
This Fund
S&P 500
This Quarter Est. Return
+13.21%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
10 Year Est. Return
AUM
$2.12B
AUM Growth
-$74.5M
Cap. Flow
-$245M
Cap. Flow %
-11.54%
Top 10 Hldgs %
5.57%
Holding
1,919
New
507
Increased
422
Reduced
518
Closed
463

Top Sells

Rank Stock Value
1
SANM icon
Sanmina
SANM
+$16.8M
2
GNTX icon
Gentex
GNTX
+$14.6M
3
ELLI
Ellie Mae Inc
ELLI
+$13.5M
4
PVA
PENN VIRGINIA CORP
PVA
+$12.1M
5
LSE
CAPLEASE, INC
LSE
+$11.5M

Sector Composition

Rank Sector Weight
1 Healthcare 13.61%
2 Industrials 13.32%
3 Technology 11.93%
4 Consumer Discretionary 9.4%
5 Financials 7.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPR
626
DELISTED
Spirit AeroSystems
SPR
$838K 0.04%
+24,580
New +$724K
BLDR icon
627
Builders FirstSource
BLDR
$7.85B
$836K 0.04%
+117,285
New +$796K
HITK
628
DELISTED
HI-TECH PHARMACAL INC
HITK
$833K 0.04%
19,199
-74,270
-79% -$3.21M
BUI icon
629
BlackRock Utilities, Infrastructure & Power Opportunities Trust
BUI
$731M
$832K 0.04%
46,550
+20,665
+80% +$366K
LHCG
630
DELISTED
LHC Group LLC
LHCG
$831K 0.04%
34,564
-53,920
-61% -$1.21M
FBIO icon
631
Fortress Biotech
FBIO
$110M
$830K 0.04%
+21,041
New +$812K
ARRS
632
DELISTED
ARRIS International plc Ordinary Shares
ARRS
$830K 0.04%
34,089
-307,596
-90% -$5.87M
XRTX
633
DELISTED
XYRATEX LTD (BERMUDA)
XRTX
$829K 0.04%
62,399
-7,832
-11% -$83.8K
ASMB icon
634
Assembly Biosciences
ASMB
$508M
$828K 0.04%
+3,611
New +$657K
ERIE icon
635
Erie Indemnity
ERIE
$12.6B
$828K 0.04%
+11,320
New +$807K
PMM
636
Franklin Managed Municipal Income Trust
PMM
$272M
$828K 0.04%
+124,697
New +$830K
PGNX
637
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$825K 0.04%
154,734
-39,167
-20% -$172K
AUQ
638
DELISTED
AURICO GOLD INC COM
AUQ
$821K 0.04%
224,435
+29,123
+15% +$112K
AGI icon
639
Alamos Gold
AGI
$12.1B
$818K 0.04%
67,464
+55,641
+471% +$753K
RCPT
640
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
$818K 0.04%
28,231
+19,870
+238% +$532K
UTL icon
641
Unitil
UTL
$1.02B
$816K 0.04%
26,755
+19,618
+275% +$591K
GIVN
642
DELISTED
GIVEN IMAGING LTD
GIVN
$809K 0.04%
26,885
-53,934
-67% -$1.26M
ONCT
643
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$805K 0.04%
349
+271
+347% +$620K
TTPH
644
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$804K 0.04%
2,974
+2,047
+221% +$488K
BEL
645
DELISTED
Belmond Ltd.
BEL
$804K 0.04%
53,207
-56,774
-52% -$810K
XCRA
646
DELISTED
Xcerra Corporation
XCRA
$803K 0.04%
100,469
-284,196
-74% -$1.94M
CNL
647
DELISTED
CLECO CRP (HOLDING CO)
CNL
$796K 0.04%
17,071
+1,180
+7% +$54.2K
UTI icon
648
Universal Technical Institute
UTI
$2.14B
$793K 0.04%
+57,038
New +$758K
FRME icon
649
First Merchants
FRME
$2.75B
$786K 0.04%
+34,590
New +$693K
FLWS icon
650
1-800-Flowers.com
FLWS
$254M
$785K 0.04%
145,069
-70,293
-33% -$357K

Similar funds

TFS Capital's Q4 2013 Portfolio in Review

As of Q4 2013, TFS Capital held 1,919 positions worth $2.12B, down 3.4% from $2.19B the previous quarter. Its ten largest holdings account for 5.6% of the portfolio.

TFS Capital withdrew a net $245M in Q4 2013, closing 463 positions and reducing 518 holdings. Its most notable exit was Gentex, an estimated $14.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 11% a quarter earlier, followed by Industrials and Technology.

Against the trend, TFS Capital opened a new position in Manitowoc worth $9.75M.

  • TFS Capital's largest Q4 2013 buy was Manitowoc: 461,718 shares worth $9.75M.
  • TFS Capital added most to UNITED ONLINE INC COM NEW in Q4 2013, an estimated $13.7M increase.
  • TFS Capital's biggest Q4 2013 reduction was Sanmina, cutting an estimated $16.8M.
  • TFS Capital fully exited Gentex in Q4 2013, selling an estimated $14.6M.
  • TFS Capital's ten largest holdings make up 5.6% of its $2.12B portfolio in Q4 2013.
  • TFS Capital opened 507 new positions and closed 463 in Q4 2013.
  • TFS Capital's portfolio value fell 3.4% quarter-over-quarter to $2.12B.

Based on TFS Capital's 13F filing for Q4 2013, filed 7 Feb 2014.